The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.
In this video, recipients of the SOHO Young Investigator Awards share how attending the SOHO Annual Meeting has expanded their clinical knowledge and professional networks while providing meaningful opportunities for mentorship and continued learning.
“AI is everywhere. Is it useful in CML? This study tests three different AI engines in their ability to answer 25 clinically meaningful questions. Do they work? Is one better than the other? Come find out.”
When SOHO was founded in 2012, we envisioned a society that would provide education, insight, connection, and meaningful opportunities for collaboration among clinicians and researchers working across the field of hematologic oncology. That vision has grown far beyond what we could have imagined. Today, SOHO is a global community of 13,000 members and counting, united by a shared commitment to advancing research, improving clinical practice, mentoring the next generation of clinicians, and delivering better treatments to patients with hematologic malignancies.
I’ve seen SOHO evolve over the dozen or so years since it was established. SOHO plays a unique role in bringing cutting-edge advances in hematologic malignancies to the broader hematology-oncology community.
Patients with low-risk myelodysplastic syndromes (LR-MDS) with bone marrow fibrosis (MF) display a cytokine pattern characterized by elevated interleukin 1β (IL-1β) and reduced interleukin 5 (IL-5), according to a presentation by Maria Stella Martino, MD, of the University of Florence in Italy and colleagues at the 2026 SOHO Annual Meeting.
In this video, Dr. Valeria Santini provides an overview of the SOHO 2026 MDS session. She covers novels agents and future research needs in the field.
SOHO Insider is the official media platform of the Society of Hematologic Oncology. The SOHO Insider Editorial Board is comprised of leading hematologists. Learn more about our editorial board and SOHO Insider platforms.
To access the SOHO Career Center click the following link.
